Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maxnerva Technology ServicesHKSE:01037 48 PS Ratio is 0.55 as of Aug. 14, 2026, which is 8% above its 10-year median of 0.51. GuruFocus rates HKSE:01037 with a GF Score™ of 48/100 and a GF Value™ of HK$0.29 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 2,786 Software companies, Maxnerva Technology Services ranks better than 84.46% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Maxnerva Technology Services's share price is HK$0.605.
Maxnerva Technology Services's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.11. Hence, Maxnerva Technology Services's PS Ratio for today is 0.55.
The historical rank and industry rank for Maxnerva Technology Services's PS Ratio or its related term are showing as below:
HKSE:01037'
s PS Ratio Range Over the Past 10 Years
Min: 0.12 Med: 0.51 Max: 12.55
Current: 0.55
During the past 13 years, Maxnerva Technology Services's highest PS Ratio was 12.55. The lowest was 0.12. And the median was 0.51.
HKSE:01037's PS Ratio is ranked better than 84.46% of 2786
companies
in the Software industry
Industry Median: 2.01
vs HKSE:01037: 0.55
Maxnerva Technology Services Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Maxnerva Technology Services was 30.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -5.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -0.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 15.80% per year.
During the past 13 years, Maxnerva Technology Services's highest 3-Year average Revenue per Share Growth Rate was 52.10% per year. The lowest was -48.20% per year. And the median was -1.15% per year.
Maxnerva Technology Services (HKSE:01037) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Maxnerva Technology Services PS Ratio Related Terms
Maxnerva Technology Services PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Information Technology Services subindustry, Maxnerva Technology Services's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maxnerva Technology Services PS Ratio vs Software Industry
For the Software industry and Technology sector, Maxnerva Technology Services's PS Ratio distribution charts can be found below:
* The bar in red indicates where Maxnerva Technology Services's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Maxnerva Technology Services's Share Price of today is HK$0.605.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maxnerva Technology Services's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Maxnerva Technology Services (HKSE:01037) has a PS Ratio of 0.55 as of Aug. 14, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Maxnerva Technology Services and its competitors. This is near median its historical median of 0.51. Over the past decade, Maxnerva Technology Services' PS Ratio has ranged from 0.12 to 12.55. According to the industry distribution chart, Maxnerva Technology Services ranks #433 out of 2786 companies in the Software industry, placing it in the top 15.5%.
Is Maxnerva Technology Services' PS Ratio too high?
Maxnerva Technology Services' current PS Ratio of 0.55 is near median its 10-year median of 0.51. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 12.55. The Software industry median PS Ratio is 2.01. Maxnerva Technology Services' value of 0.55 is 72.6% below this industry median. Based on the distribution chart, Maxnerva Technology Services ranks #433 out of 2786 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Maxnerva Technology Services has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Maxnerva Technology Services' PS Ratio compare to IBM and ACN?
According to the Software industry distribution chart, Maxnerva Technology Services ranks #433 out of 2786 companies for PS Ratio. This places Maxnerva Technology Services in the top 16% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.01. Maxnerva Technology Services' value of 0.55 is 72.6% below this benchmark. Historically, Maxnerva Technology Services' own PS Ratio has ranged from 0.12 to 12.55 over the past decade. While the company's 10-year median is 0.51 vs. the industry median of 2.01, Maxnerva Technology Services has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Software company?
The median PS Ratio among Software companies is 2.01, based on 2,786 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maxnerva Technology Services's current PS Ratio of 0.55 is 72.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Maxnerva Technology Services and its competitors. For the Software industry, the median PS Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maxnerva Technology Services's current PS Ratio is 0.55, which is near median its own 10-year median of 0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maxnerva Technology Services stock overvalued right now?
Based on GuruFocus' analysis, Maxnerva Technology Services (HKSE:01037) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.61 — trading 108.6% above its estimated fair value. The current PS Ratio is 0.55, which is near median its 10-year median of 0.51 and 72.6% below the Software industry median of 2.01. Maxnerva Technology Services' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Maxnerva Technology Services (HKSE:01037), the current PS Ratio is 0.55 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maxnerva Technology Services (HKSE:01037) Overvalued in 2026?
Based on GuruFocus' analysis, Maxnerva Technology Services stock appears to be overvalued.
The current stock price of HK$0.61 is trading 108.6% above its estimated GF Value™ of HK$0.29.
GuruFocus considers Maxnerva Technology Services to be Significantly Overvalued.
Key valuation signals for HKSE:01037:
PS Ratio: 0.55 (near median its 10-year median of 0.51)
GF Value™: HK$0.29 vs. price of HK$0.61 (108.6% above fair value)
Industry Position: 72.6% below the Software median (#433 of 2786)
No single metric tells the full story. See the HKSE:01037 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maxnerva Technology Services Ltd provides a range of smart manufacturing solutions and services to customers, including the implementation of a combination of software systems and automation equipment and robots into the production lines to lower costs and increase operational effectiveness and efficiency through smart processes; the implementation of facility monitor and control system for monitoring the efficiency of the usage of water, power, and gas at production plants; the implementation of facial recognition system for labor and security management of the entire industrial parks; and the provision of testing and inspection services for new and existing electronic products. Its segments are Digital Industry Business which derives the majority of revenue, and Digital Life Business.
48GF Score
Get the complete analysis for HKSE:01037
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01037 has been successfully added to your 
